ENTRY       D10779            Mixture   Drug
NAME        Ceftazidime and avibactam;
            Avycaz (TN);
            Zavicefta (TN)
  ABBR      CZA
PRODUCT     AVYCAZ (Allergan)
COMPONENT   (Ceftazidime hydrate [DR:D00921] | Ceftazidime [DR:D07654]), Avibactam sodium [DR:D10340]
REMARK      ATC code: J01DD52
            Product: D10779<US>
EFFICACY    Antibacterial
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J01 ANTIBACTERIALS FOR SYSTEMIC USE
               J01D OTHER BETA-LACTAM ANTIBACTERIALS
                J01DD Third-generation cephalosporins
                 J01DD52 Ceftazidime and beta-lactamase inhibitor
                  D10779  Ceftazidime and avibactam &lt;US&gt;
            USP drug classification [BR:br08302]
             Antibacterials
              Beta-lactam, Cephalosporins
               Ceftazidime/ Avibactam
                D10779  Ceftazidime and avibactam
            Antimicrobials [BR:br08307]
             Antibacterials
              Cell wall biosynthesis inhibitor, beta-lactam
               Third-generation cephalosporin
                D10779  Ceftazidime and avibactam &lt;US&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antibacterials
              Cell wall biosynthesis inhibitor, beta-lactam
               Third-generation cephalosporin
                D10779  Ceftazidime and avibactam
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10779
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10779
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10779
DBLINKS     PubChem: 313046637
///
